News

The French Ministry for Higher Education and Research extended Comac Medical’s approval as a research and development service provider

We have the pleasure to announce that the French Ministry for Higher Education and Research has granted an extension to the approval of Comac Medical’s Clinical Research Unit (CRU) as a research and development service provider. This allows companies, subject to the French General Tax Code, to take advantage of the research and development tax credit (Le Crédit d’Impôt Recherche (CIR) available in France.

French companies which have outsourced research and development to Comac Medical’s CRU will be able to benefit from the research and development tax credit (Le Crédit d’Impôt Recherche (CIR).

The open-data list of approved organizations is available at: https://lnkd.in/dwkdAcU

 

MEDICAL CENTER COMAC MEDICAL LTD – décision – Agr CIR

Share:
Clinical trials are the backbone of medical advancements, they ensure that new treatments undergo rigorous evaluation for safety...
Skin conditions are among the most common health issues worldwide, impacting millions and posing significant challenges to healthcare...
Each year, on the last day of February, the world comes together to recognize Rare Disease Day, in...